All day
Place: ICFO Auditorium
PHAST- ETN: Photonics for Healthcare: multiscale cancer diagnosis and therapy
On Thursday, 19th of September, the closing meeting of The European Training Network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy) will be held at ICFO.
The project aimed to address some relevant “unmet needs” of the medical community in the prevention, diagnosis and treatment of cancer – one of the leading causes of death worldwide – to significantly improve the quality of life for European society. The main scientific goal of PHAST was to develop multiscale advanced photonic technologies for the diagnosis of cancer in vitro and in vivo and the monitoring of therapy for personalized medicine, through four specific objectives: in vitro diagnosis, tissue diagnostics and functional monitoring, microscale cancer monitoring and macroscale therapy effectiveness monitoring.
The research was conducted by 15 Early Stage Researchers (ESR), enrolled in highly multidisciplinary PhD programs at different research institutions across 7 different European countries over the past four years. PHAST-ETN project was supported by 8 partner organizations, of which 5 companies and 3 research institutes, including some globally recognized names in the field, such as Horiba, Philips and Zeiss.
More info available at the official website https://www.phast-eu.unipr.it/
The plenary speech will be conducted by Prof. Martin Leahy (University of Galway).
"The evolution of mobile and wearable non-invasive health monitoring"
Abstract:
The heart rate app dominates publications and app downloads in both photonics and medicine. While there were mobile health activities prior to 2009, the advent of mobile heart rate measurement and the app stores brought this to the mainstream. Steps, heart rate variability, perfusion index, alcohol, SpO2 and hydration are among those added. The capabilities of existing technologies don’t always match needs and it is difficult to make a use case for some offerings. It is therefore useful to step back and look at the major needs and on the unmet clinical side these would include: blood pressure, sodium, blood glucose and ketones.
Bio:
Martin Leahy is the Established Chair of Applied Physics at the University of Galway and Distinguished Visiting Professor at ICFO, Barcelona. He is a serial entrepreneur having been technical and/or executive lead of several successful spin-out companies in biophotonics and energy. He is founder and Chair of the International Biophotonics and Imaging Graduate Summer School (BIGSS - http://tinyurl.com/yrf27jwb). His group invented the heart rate app which is now in use by more than 500 million people as well as cmOCT to image the microcirculation, nanosensitive OCT to sense nanostructure and multiple reference OCT to achieve a 100-fold reduction in size and cost. More recently, his group have developed a label-free super-resolution microscope and synthetic OCT. He secured more than €14M in external R&D funding since 2007. He has a DPhil in Biophotonics from Oxford, is a Fellow of IoP, SPIE and Optica. Prof. Leahy delivered more than 60 invited and keynote lectures in Europe, China, Russia and USA.
PROGRAM:
11:00 – 11:05 Opening and welcome; Turgut Durduran, ICFO
11:05 – 11:30 Introduction by the coordinator and a brief presentation of the project and the results. Daniel Milanese, PHAST Project Coordinator
11:30 – 12:30 " The evolution of mobile and wearable non-invasive health monitoring", Martin Leahy (University of Galway)
12:30 – 13:30 Lunch
All day
Place: ICFO Auditorium
PHAST- ETN: Photonics for Healthcare: multiscale cancer diagnosis and therapy
On Thursday, 19th of September, the closing meeting of The European Training Network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy) will be held at ICFO.
The project aimed to address some relevant “unmet needs” of the medical community in the prevention, diagnosis and treatment of cancer – one of the leading causes of death worldwide – to significantly improve the quality of life for European society. The main scientific goal of PHAST was to develop multiscale advanced photonic technologies for the diagnosis of cancer in vitro and in vivo and the monitoring of therapy for personalized medicine, through four specific objectives: in vitro diagnosis, tissue diagnostics and functional monitoring, microscale cancer monitoring and macroscale therapy effectiveness monitoring.
The research was conducted by 15 Early Stage Researchers (ESR), enrolled in highly multidisciplinary PhD programs at different research institutions across 7 different European countries over the past four years. PHAST-ETN project was supported by 8 partner organizations, of which 5 companies and 3 research institutes, including some globally recognized names in the field, such as Horiba, Philips and Zeiss.
More info available at the official website https://www.phast-eu.unipr.it/
The plenary speech will be conducted by Prof. Martin Leahy (University of Galway).
"The evolution of mobile and wearable non-invasive health monitoring"
Abstract:
The heart rate app dominates publications and app downloads in both photonics and medicine. While there were mobile health activities prior to 2009, the advent of mobile heart rate measurement and the app stores brought this to the mainstream. Steps, heart rate variability, perfusion index, alcohol, SpO2 and hydration are among those added. The capabilities of existing technologies don’t always match needs and it is difficult to make a use case for some offerings. It is therefore useful to step back and look at the major needs and on the unmet clinical side these would include: blood pressure, sodium, blood glucose and ketones.
Bio:
Martin Leahy is the Established Chair of Applied Physics at the University of Galway and Distinguished Visiting Professor at ICFO, Barcelona. He is a serial entrepreneur having been technical and/or executive lead of several successful spin-out companies in biophotonics and energy. He is founder and Chair of the International Biophotonics and Imaging Graduate Summer School (BIGSS - http://tinyurl.com/yrf27jwb). His group invented the heart rate app which is now in use by more than 500 million people as well as cmOCT to image the microcirculation, nanosensitive OCT to sense nanostructure and multiple reference OCT to achieve a 100-fold reduction in size and cost. More recently, his group have developed a label-free super-resolution microscope and synthetic OCT. He secured more than €14M in external R&D funding since 2007. He has a DPhil in Biophotonics from Oxford, is a Fellow of IoP, SPIE and Optica. Prof. Leahy delivered more than 60 invited and keynote lectures in Europe, China, Russia and USA.
PROGRAM:
11:00 – 11:05 Opening and welcome; Turgut Durduran, ICFO
11:05 – 11:30 Introduction by the coordinator and a brief presentation of the project and the results. Daniel Milanese, PHAST Project Coordinator
11:30 – 12:30 " The evolution of mobile and wearable non-invasive health monitoring", Martin Leahy (University of Galway)
12:30 – 13:30 Lunch